Posts Tagged ‘Health Canada’

Is ADHD a Fictional Disease?

Saturday, May 21st, 2011

Some psychiatrists argue that ADHD is little more than a marketing gimmick

The Mark
By Fred Baughman
May 18, 2011

Dr. Fred Baughman, Child neurologist; opponent of ADHD diagnosis

Some 5.4 million children in the United States have been diagnosed with attention-deficit hyperactivity disorder, or ADHD, with two-thirds of them taking psychiatric drugs. Sales of ADHD drugs reached $1.2 billion in 2010, a demand level so high that the U.S. is experiencing an ADHD drug shortage. But an increasingly vocal contingent of psychiatric experts is speaking up against diagnosing children with ADHD, arguing it is a non-existent condition drummed up by pharmaceutical companies to increase sales.

What makes you convinced that ADHD is not a real disease?

During my time in practice, I’ve authored papers and discovered real diseases and so on. Psychiatry in 1948 was distinguished from neurology. Neurology is the specialty dealing with physical and organic diseases of the brain and nervous system. Psychiatry is the specialty dealing with emotional and behavioural things which are not actual, physical diseases – things like depression, anxiety, panic, and so on.

Insofar as ADHD is concerned, it seems clear that in the ’50s, as the first psychiatric drugs came to market, that psychiatry – in cahoots with the pharmaceutical industry – came upon the market strategy of, “Well, we’ll call these things ‘diseases.’” And the prototypical invented disease was called ADHD.

It was initially in a 1970 congressional hearing in the U.S. that psychiatrists appeared and testified that, what was then called hyper kinetic disorder or minimal brain dysfunction, was a disease that needed diagnosing by a physician, and as a disease it justified the use of drugs to treat it. So that was the official beginning of ADHD in particular and of psychiatric diagnoses in general as being due to a disease of the brain. In every case, they say there’s a subtle chemical imbalance in the brain, which of course they never have a means of diagnosing in life and have never in scientific literature authored proof that there is in fact a disease. And yet they are allowed by [the U.S.] Food and Drug Administration to say that there is a chemical imbalance and that the drugs balance the imbalance.

So it’s been a market strategy. This lie has been allowed to be published by the drug industry and by psychiatry, by our regulatory agencies, specifically the Food and Drug Administration. So that’s where we are today.

All physicians learn in medical school that a disease is a physical abnormality. When you go to your physician, they may see a rash or they may find something microscopically abnormal, such as cancer cells. Then there are a lot of chemical diseases – diabetes being the best known. There are about a hundred examples of inborn errors of metabolism or body chemistry. These can all be tested for, they’ve all been proven, and they exist in the scientific literature – whereas there is not a single psychiatric diagnosis that exists in scientific literature of the world.

In 2008, I was counselling a young father from Kingston, Ont., who was in a divorce situation, and the mother insisted the children be seen by psychiatrists and the psychiatrist had made a number of diagnoses and had this one boy on large amounts of about five or six different types of medication. I helped the father author a letter to Health Canada asking where – in the case of ADHD or any psychiatric diagnosis – there is proof of a gross or microscopic abnormality.

This gentleman got a letter back from the director-general of Health Canada saying there is no gross, microscopic, or chemical abnormality in any psychiatric diagnosis; there is no objective way of verifying a psychiatric diagnosis as a disease.

That’s why psychiatry’s claims that their diagnoses are chemical imbalances is nothing but a lie and a deception. And yet, because of their financial might on the world scene, no one will challenge them. They have friends bought and paid for in government and in all of the governmental health-care agencies.

Here in the States, as of 2007, the Centers for Disease Control announced that 5.4 million U.S. schoolchildren five to 17 years old had ADHD. And you can be sure that they have all been on ADHD drugs, which are, for the most part, amphetamines, which are known to be addictive, dangerous, deadly.

I’ve heard estimates of 20 per cent of schoolchildren in the U.S. with a psych diagnosis and who were on psych drugs. It’s exploding, it’s increasing all the time.

Is the issue that we’re overmedicating ourselves, or that ADHD is not real?

When it’s a total fraud, you don’t call it overmedicating. There is no such thing as ADHD as a disease, so there is never justification for it. It’s a total fraud.

What is there to gain from diagnosing children with ADHD?

Ritalin has passed $1 billion a year in sales. Ritalin is no longer the top ADHD drug in the U.S. I think Adderall, which is made up of amphetamines, passed Ritalin a few years ago in market share.

It’s a complete fraud, they’ve invented diseases for which their drugs are a cure. The rate of diagnosing ADHD has been going up by a million a year in the U.S. This is a market strategy.

The book Selling Sickness: How the World’s Biggest Pharmaceutical Companies Are Turning Us All Into Patients [by Ray Moynihan and Alan Cassels] talks generally about inventing diseases for which to sell drugs. In the foreword of that book, the authors quote the former president of Merck Pharmaceutical Co., Henry Gadsden, who once said he was anxious to find ways to market his products to normal people, just like the Wrigley chewing gum people did. This was kind of an after-the-fact confession they were trying to market drugs to normal people, and calling all psychological dilemmas diseases for which they needed a pill. This was the strategy.

It’s almost unimaginable, it’s almost unthinkable that this has been going on, but that’s exactly what’s been going on.

How would you diagnose a child that was considered to have ADHD?

Look at the criteria that are used to call a child ADHD. They talk out of turn, they don’t sit still, they wiggle around too much in their seats, they are impulsive, disorderly, and so on. It’s a bunch of behaviours that are seen in just about every child at some stage of their life. This is by design; they have taken kind of irritating, bothersome, disruptive behaviours in children and have kind of cobbled them together and called it a disease.

They get a lot of parents to buy it because a lot of parents are now busy with their job in the workforce and there’s no longer a full-time parent in the home, and so, “Here’s why Johnny or Janey is such an irritant to me, they’ve got ADHD.” It takes the pressure entirely off the parent for not being a presence and for not being there full-time to mould the behaviour of the child, and they’re calling these behaviours a disease and saying we’ve got a pill for it. That’s very seductive. That’s a far more appealing analysis than, “Gee, you’re divorced, there’s no one in the home to discipline the child real time,” and so on.

These are not diseases, they are behaviours. Today, you hang a psychiatric label on a child, you surely stigmatize the child and these drugs are exceedingly dangerous. In 2005, there were several deaths in Canada of young children from Adderall. It was temporarily taken off the market, but then the power of the industry won out and Adderall’s back on the market. Pure amphetamines.

Read article here:  http://www.themarknews.com/articles/5193-is-adhd-a-fictional-disease?page=1

« Return to news items


Share

Jury recommends major reforms in drug prescribing after investigation of 18-year-old’s suicide under the influence of Paxil

Wednesday, June 30th, 2010

Pharmalot
By Ed Silverman
June 30, 2010

There have been numerous claims that a medication caused a suicide, but few lead to sweeping changes. In Canada, however, the suicide of 18-year-old Sarah Carlin, who had taken the Paxil antidepressant, is a clear exception. Following a coroner’s inquest, Canada’s provincial and federal governments were told to ensure patients are better informed about drug risks, tighten regulations on drugmakers and establish an independent agency to regulate medications.

“If these things had been in place at the time Sara was prescribed Paxil, she would be alive today,” her father, Neil Carlin, said outside court. “We consider this a great victory…We are truly confident that if these are acted upon there will be young lives saved down the road.”

For more than a year before her death, Sara had been taking Paxil, an anti-depressant, which Health Canada warns can increase the risk of suicidal events in children and adolescents under 18. The teenager hanged herself in her parents’ basement in May 2007. The inquest made numerous recommendations, which you can see if you keep reading…

Of the various recommendations, the one that is garnering the most discussion appears to be the creation of a Drug Safety Board to investigate the side effects and issue warnings to the public, doctors and hospitals. The inquest specifically recommended the new board not receive any funding from drugmakers. Drugmakers must also report all adverse events to Health Canada within 30 days.

A Glaxo spokeswoman writes to says the drugmaker “is supportive of appropriate recommendations designed to prevent similar tragedies from occurring in the future, and will give the recommendations addressed to the broader pharmaceutical industry our full attention and consideration. Sara Carlin’s death was a tragedy and we continue to express our deepest sympathies to her family.”

1. The Ministry of Health and Long-Term Care (MOHLTC) should develop a Drug Information System. This system would promote:
• Patient safety in the prescribing and dispensing of drugs.
• Collection and compilation of data in a single repository for all drugs dispensed for all Ontarians.
• Research into drug and patient safety.

2. The Drug Information System should track and monitor all drugs dispensed in Ontario regardless of who is paying for the prescription.

3. The Drug Information System should collect, compile and release data upon request to scientists such as those studying population-based health outcomes at the Institute for Clinical Evaluative Sciences.

4. The Ministry of Health and Long-Term Care should commit to developing a province-wide suicide prevention strategy as has occurred in other provinces such as Alberta.

5. The objectives of the province-wide suicide prevention strategy should include:
• Enhanced mental health and well being for Ontarians.
• The education of the public to de-stigmatize mental health disorders, including depression and substance abuse disorders.
• Improving intervention and support for Ontarians affected by depression and substance abuse.
• Improving intervention and treatment for those at risk of suicide.
• Increased efforts to reduce access to lethal means of suicide.
• Increased research activities in Ontario on suicide, suicidal behaviour and suicide prevention.
• Improved suicide and suicidal behaviour-related surveillance systems.
• Inform and educate the media into strategies when reporting deaths due to suicide to prevent ‘copy cat’ suicides from occurring.

6. Strategies in the province-wide suicide prevention strategy should be humane, effective and evidence based, respectful of community and culture-based knowledge, inclusive of research, surveillance, evaluation and reporting and reflective of evolving knowledge and practices.

7. The ministry of Health and Long-Term Care of Ontario and Government of Ontario should commit to supporting the development of a national suicide prevention strategy for all Canadians.

Read entire article:  http://www.pharmalot.com/2010/06/sara-carlin-paxil-and-drug-safety-in-canada/

« Return to news items


Share

Toronto Sun—“The girl with every reason to live” Parents blame daughter’s suicide on antidepressant Paxil

Saturday, June 12th, 2010

Toronto Sun
By Michelle Mandel
June 12, 2010

Sara Carlin had everything to live for: She was smart, athletic, beautiful and pursuing her dream of becoming a doctor.

But on May 6, 2007, that bright future ended abruptly with a piece of electrical wire.

The promising 18-year-old had hung herself in her family’s Oakville basement and her grieving parents blame her suicide on the Paxil antidepressant she’d been prescribed more than a year before.

In emotional testimony that left many fighting back tears, Sara’s mother Rhonda told a coroner’s inquest that her daughter earned 90’s in school, played baseball and women’s hockey, held a part-time job at an optometrist’s office and tutored other kids in math.

“She was a pretty exceptional girl, she was absolutely loving and she was beautiful,” her mom proudly recalled Wednesday before the presiding coroner, Dr. Bert Lauwers. “She really was an exceptional daughter.”

But in the early part of 2006, Sara began to change. During the family’s March break vacation to Palm Springs, she wouldn’t get out of bed most days and got drunk at dinner. “It was so unlike her,” her mom said.

It was only later that she learned Sara had complained of anxiety and depression to her family doctor and had recently been prescribed Paxil, one of the antidepressants known as selective serotonin reuptake inhibitors (SSRIs).

“I said, ‘Why on earth, Sara would you be on antidepressants?’ I was astounded,” she recalled for the five-member jury. “Why, why would he be giving these to her? This was a wonderful, happy girl.”

While Sara lost her much older brother to a drug overdose in 2000, her mother believed her daughter had coped well with his death and never wanted the counselling she’d been offered.

So this need for antidepressants, she said, came out of the blue.

“She was very troubled, much more troubled than any of us knew,” her mother acknowledged.

While her parents repeatedly voiced their reservations about Paxil, Sara brushed them off, saying her doctor told her it would make her feel better. “I didn’t even know the horrific side effects of Paxil at that time,” her mom said. “I certainly didn’t know what I know now.”

Health Canada issued warnings in 2003 and 2004 that prescribing antidepressants to teens could lead to behavioural or emotional changes that might put them at increased risk of suicidal behaviour.

Read entire article:  http://www.torontosun.com/news/columnists/michele_mandel/2010/06/10/14340951.html

« Return to news items


Share